Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06905314
PHASE1
A Single Ascending Dose of HRS-4029 in Healthy Subjects
Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
View on ClinicalTrials.gov
Summary
The study is being conducted to evaluate the safety, tolerability and pharmacokinetics of HRS-4029 following a single intravenous dose administration in healthy subjects.
Official title: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HRS-4029 Following a Single Dose in Healthy Subjects
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
55
Start Date
2025-04
Completion Date
2025-12
Last Updated
2025-04-01
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
HRS-4029
HRS-4029
DRUG
Placebo
Placebo
Locations (1)
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China